Health Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford
Health KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use
Health Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss
Money Missed Out on Eli Lilly’s 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
